Credit Suisse Ag Immunity Bio, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 1,548,826 shares of IBRX stock, worth $6.95 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,548,826

Previous 1,529,908 1.24%

Holding current value

$6.95 Million

Previous $7.68 Million 8.29%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$3.23 - $6.17 $61,105 - $116,724	18,918 Added 1.24%	1,548,826 $8.32 Million
Q4 2023 Feb 08, 2024	SELL	$1.25 - $5.21 $5,286 - $22,033	-4,229 Reduced 0.28%	1,529,908 $7.68 Million
Q3 2023 Nov 13, 2023	BUY	$1.29 - $3.1 $667,759 - $1.6 Million	517,643 Added 50.92%	1,534,137 $2.59 Million
Q2 2023 Aug 11, 2023	BUY	$1.53 - $6.41 $193,996 - $812,755	126,795 Added 14.25%	1,016,494 $2.83 Million
Q1 2023 May 10, 2023	BUY	$1.35 - $4.78 $269,952 - $955,832	199,965 Added 28.99%	889,699 $1.62 Million
Q4 2022 Feb 13, 2023	SELL	$4.35 - $6.77 $36,183 - $56,312	-8,318 Reduced 1.19%	689,734 $3.5 Million
Q3 2022 Nov 10, 2022	BUY	$3.65 - $6.43 $34,959 - $61,586	9,578 Added 1.39%	698,052 $3.47 Million
Q2 2022 Aug 12, 2022	BUY	$2.68 - $6.14 $619,077 - $1.42 Million	230,999 Added 50.49%	688,474 $2.56 Million
Q1 2022 May 16, 2022	BUY	$5.05 - $7.53 $134,941 - $201,209	26,721 Added 6.2%	457,475 $2.57 Million
Q4 2021 Feb 14, 2022	BUY	$5.67 - $10.18 $221,657 - $397,966	39,093 Added 9.98%	430,754 $2.62 Million
Q3 2021 Nov 12, 2021	BUY	$9.17 - $14.24 $1.96 Million - $3.04 Million	213,636 Added 120.0%	391,661 $3.82 Million
Q2 2021 Aug 16, 2021	SELL	$13.41 - $22.4 $54,243 - $90,608	-4,045 Reduced 2.22%	178,025 $2.54 Million
Q1 2021 May 14, 2021	BUY	$12.83 - $42.25 $2.34 Million - $7.69 Million	182,070 New	182,070 $4.32 Million

Others Institutions Holding IBRX

# of Institutions

202

Shares Held

70M

Call Options Held

1.68M

Put Options Held

1.31M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account